A few months ago the Food and Drug Administration (FDA) made waves by approving a cannabis-based medication for the first time ever. And now that medication is finally available to the public.
Epidiolex is now available to be prescribed in all 50 states.
The medication is meant for people who suffer from either Dravet syndrome or Lennox-Gastaut syndrome, both of which are conditions that cause seizures starting at an early age.
Both of these conditions are known to be resistant to traditional forms of seizure medication, but have been managed and controlled through administration of cannabidiol (CBD).
Click here to read the complete article
Joseph Misulonas ~ Civilized.life ~
